BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21471709)

  • 1. FLNA and PGK1 are two potential markers for progression in hepatocellular carcinoma.
    Ai J; Huang H; Lv X; Tang Z; Chen M; Chen T; Duan W; Sun H; Li Q; Tan R; Liu Y; Duan J; Yang Y; Wei Y; Li Y; Zhou Q
    Cell Physiol Biochem; 2011; 27(3-4):207-16. PubMed ID: 21471709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of phosphoglycerate kinase 1 on metastasis and invasion of hepatoma cells and prognosis of liver cancer].
    Zhang L; Wang YC; Xie XY; Chen J; Gao DM; Ren ZG
    Zhonghua Gan Zang Bing Za Zhi; 2017 Jun; 25(6):446-451. PubMed ID: 28763863
    [No Abstract]   [Full Text] [Related]  

  • 3. Nucleolin identified by comparative mass‑spectra analysis is a potential marker for invasive progression of hepatocellular carcinoma.
    Qian B; Yao Y; Liu Y; Yan M; Huang Y; Chen Y
    Mol Med Rep; 2014 Sep; 10(3):1489-94. PubMed ID: 24927373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PGK1 Drives Hepatocellular Carcinoma Metastasis by Enhancing Metabolic Process.
    Xie H; Tong G; Zhang Y; Liang S; Tang K; Yang Q
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28749413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative proteomics reveals FLNC as a potential progression marker for the development of hepatocellular carcinoma.
    Qi Y; Xu F; Chen L; Li Y; Xu Z; Zhang Y; Wei W; Su N; Zhang T; Fan F; Wang X; Qin X; Zhang L; Liu Y; Xu P
    Oncotarget; 2016 Oct; 7(42):68242-68252. PubMed ID: 27626164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gelsolin-like Actin-capping Protein (CapG) Overexpression in the Cytoplasm of Human Hepatocellular Carcinoma, Associated with Cellular Invasion, Migration and Tumor Prognosis.
    Tsai TJ; Chao WY; Chen CC; Chen YJ; Lin CY; Lee YR
    Anticancer Res; 2018 Jul; 38(7):3943-3950. PubMed ID: 29970516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of biomarkers for screening hepatocellular carcinoma using global data mining and multiple reaction monitoring.
    Kim H; Kim K; Yu SJ; Jang ES; Yu J; Cho G; Yoon JH; Kim Y
    PLoS One; 2013; 8(5):e63468. PubMed ID: 23717429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
    Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
    Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronin-1C is a novel biomarker for hepatocellular carcinoma invasive progression identified by proteomics analysis and clinical validation.
    Wu L; Peng CW; Hou JX; Zhang YH; Chen C; Chen LD; Li Y
    J Exp Clin Cancer Res; 2010 Feb; 29(1):17. PubMed ID: 20181269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Filamin A expression predicts early recurrence of hepatocellular carcinoma after hepatectomy.
    Donadon M; Di Tommaso L; Soldani C; Franceschini B; Terrone A; Mimmo A; Vitali E; Roncalli M; Lania A; Torzilli G
    Liver Int; 2018 Feb; 38(2):303-311. PubMed ID: 28727243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers.
    Rong Y; Chen H; Zhou XF; Yin CQ; Wang BC; Peng CW; Liu SP; Wang FB
    Oncotarget; 2016 Feb; 7(7):8282-94. PubMed ID: 26882565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tensin2 variant 3 is associated with aggressive tumor behavior in human hepatocellular carcinoma.
    Yam JW; Ko FC; Chan CY; Yau TO; Tung EK; Leung TH; Jin DY; Ng IO
    Hepatology; 2006 Oct; 44(4):881-90. PubMed ID: 17006924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy.
    Yuan SX; Yang F; Yang Y; Tao QF; Zhang J; Huang G; Yang Y; Wang RY; Yang S; Huo XS; Zhang L; Wang F; Sun SH; Zhou WP
    Hepatology; 2012 Dec; 56(6):2231-41. PubMed ID: 22706893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Increased coronin-1C expression is related to hepatocellular carcinoma invasion and metastasis].
    Wu L; Hou JX; Peng CW; Zhang YH; Chen C; Chen LD; Li Y
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jul; 18(7):516-9. PubMed ID: 20678442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Filamin A and Filamin B are co-expressed within neurons during periods of neuronal migration and can physically interact.
    Sheen VL; Feng Y; Graham D; Takafuta T; Shapiro SS; Walsh CA
    Hum Mol Genet; 2002 Nov; 11(23):2845-54. PubMed ID: 12393796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiam1 is associated with hepatocellular carcinoma metastasis.
    Huang J; Ye X; Guan J; Chen B; Li Q; Zheng X; Liu L; Wang S; Ding Y; Ding Y; Chen L
    Int J Cancer; 2013 Jan; 132(1):90-100. PubMed ID: 22573407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel inhibitor of PGK1 suppresses the aerobic glycolysis and proliferation of hepatocellular carcinoma.
    Li M; Zhang A; Qi X; Yu R; Li J
    Biomed Pharmacother; 2023 Feb; 158():114115. PubMed ID: 36516697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
    Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
    Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.
    Sueoka S; Kanda M; Sugimoto H; Shimizu D; Nomoto S; Oya H; Takami H; Ezaka K; Hashimoto R; Tanaka Y; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1453-60. PubMed ID: 25805236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.